2027届-工程细胞株构建研究员-苏州(J25150)当面告知
上海药明康德新药开发有限公司
2026-12-16 16:04:35
校招博士27届硕士
岗位详情
地区:
苏州市
专业要求:
医学分子生物学医学细胞生物学
岗位职责:
1. Proficient in plasmid vector design and construction strategies, skilled in sequence alignment and analysis techniques, with extensive experience in designing sgRNA and shRNA/siRNA.
2. Establish cell-based in vitro evaluation methods to assess the biological activity of compounds.
3. Participate in the entire process of cell line construction projects, including CRISPR-mediated gene editing and the generation of stable cell lines via lentiviral infection.
4. Participate in cell line validation, develop, and validate relevant experimental methods (e.g., CTG, TPD, RT-qPCR, Western Blot, FACS) tailored to different cell lines. Proactively explore cutting-edge new technologies, methods, or tools.
5. Conduct functional experiments using standard passaged cell lines or genetically edited cells to validate the degradation effects of PROTAC molecules and investigate their mechanisms of action.
6. Accurately and timely complete laboratory notebooks in both Chinese and English. Prepare experimental reports in both Chinese and English.
7. Participate in the daily operation, maintenance, and instrument management of BSL-2 laboratory.
招聘要求:
1. Master's degree or higher in Biochemistry, Molecular Biology, Cell Biology, or a related biological science field.
2. Proficient in molecular and cell biology techniques such as electroporation transfection, lentivirus infection, TPD, CTG, NanoBRET, PCR, RT-qPCR, Western Blot, FACS, etc.
3. Proficient with standard Office software. Familiar with common biological data analysis and statistical software (e.g., Prism). Capable of independent experimental design and result analysis.
4. Strong Chinese and English written communication skills. Ability to read and comprehend scientific literature in English fluently.
5. Ability to work independently and solve problems. Strong communication and coordination skills, team-oriented, and collaborative.
公司介绍
上
上海药明康德新药开发有限公司
上海药明康德新药开发有限公司,成立于2002-04-02,位于上海,法定代表人:张朝晖,登记状态:存续,注册资本258164.4303万人民币,公司类型:民营/私企
公司信息:公司名称:上海药明康德新药开发有限公司公司类型:互联网/电子商务公司性质:5000以上公司地点:公司规模:--涉及领域:--公司网址: